Most Volatile Mover within Traders Spotlight: ImmunoCellular Therapeutics, Ltd.’s (IMUC)
ImmunoCellular Therapeutics, Ltd.’s (IMUC) stock price escalated 22.31% to finalize at $2.96 throughout previous buying and selling session. A total of 1.91 million shares exchanged at hands and its average trading volume is standing at 0.28 million shares.
The Stock has Weekly volatility of 16.22% and monthly volatility of 10.60%. Tracking most recent quarter period, Price to book (P/B) ration is at 29.60 and Price to cash per share ration is at 0.66. Beta value of the stock is marked at 0.54. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security’s price will be more volatile than the market. The company has a Return on Assets (ROA) of -85.50%. Presently, it has a Return on Equity (ROE) of -133.20%.
Important factors to focus when evaluating a stock’s present and future value are the 52 week price high and low levels. Shares of ImmunoCellular Therapeutics, Ltd.’s (IMUC) are trading -30.66% downward from the 52-week high mark and 4658.84% above from the fifty two-week low mark.
While taking a glance at financials, we can look at a number of key indicators about ImmunoCellular Therapeutics, Ltd.’s (IMUC) . Average true range (ATR-14) of the company is at 0.36. Developed by J. Welles Wilder, ATR is an indicator that measures volatility. A stock experiencing a high level of volatility has a higher ATR, and a low volatility stock has a lower ATR. It may be used by market technicians to enter and exit trades, and it is a useful tool to add to a trading system.
Taking a glance at past performance, we will examine different up or down moving trends about IMUC. The stock added 17.00% beyond one week and climbed 7.64% during previous one month session. The stock went up 3411.27% at some stage in past quarter. Inside the closing six months period the stock’s performance raised 2208.89% while overall yearly performance gained 1136.42%. The Company’s year to date (YTD) performance is now positive at 44.39%.
Relative strength index (RSI-14) for ImmunoCellular Therapeutics, Ltd.’s (IMUC) is at 61.98. In phrases of Market analysis and buying and selling signals, RSI moving above the horizontal 30 reference standard is regarded as a bullish indicator, at the same time as the RSI transferring under the horizontal 70 reference standard is visible to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely moves underneath 30 notify oversold conditions.
ImmunoCellular Therapeutics, Ltd.’s (IMUC) stock price distance from twenty day simple moving average surged at 19.70% while its distance from fifty day simple moving average raised 21.46% along with 253.59% above distance from two hundred simple moving averages. On technical aspect, moving averages may help to distinguish path of dispositions, and they may also be used to set degrees of support and resistance. Tracking the stock price in relation to moving averages as well as highs and lows for the year might assist with evaluating future stock performance.
The company’s quick ratio for most recent quarter is 9.80. Its Current ratio for most recent quarter of 9.80. Total debt to equity ratio of the company for most recent quarter is 0.00 while Long term debt to equity ratio for same time period is 0.00.